These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


303 related items for PubMed ID: 23224615

  • 1. Genetic association of IFN-γ +874T/A polymorphism in Mexican patients with drug-induced Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Charli-Joseph Y, Lima G, Ramos-Bello D, Aguilar D, Orozco-Topete R, Llorente L.
    Arch Dermatol Res; 2013 May; 305(4):353-7. PubMed ID: 23224615
    [Abstract] [Full Text] [Related]

  • 2. Association of combined IL-13/IL-4R signaling pathway gene polymorphism with Stevens-Johnson syndrome accompanied by ocular surface complications.
    Ueta M, Sotozono C, Inatomi T, Kojima K, Hamuro J, Kinoshita S.
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1809-13. PubMed ID: 18263811
    [Abstract] [Full Text] [Related]

  • 3. Strong association between HLA-B*5801 and allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in a Thai population.
    Tassaneeyakul W, Jantararoungtong T, Chen P, Lin PY, Tiamkao S, Khunarkornsiri U, Chucherd P, Konyoung P, Vannaprasaht S, Choonhakarn C, Pisuttimarn P, Sangviroon A, Tassaneeyakul W.
    Pharmacogenet Genomics; 2009 Sep; 19(9):704-9. PubMed ID: 19696695
    [Abstract] [Full Text] [Related]

  • 4. A study of HLA class I and class II 4-digit allele level in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Cristallo AF, Schroeder J, Citterio A, Santori G, Ferrioli GM, Rossi U, Bertani G, Cassano S, Gottardi P, Ceschini N, Barocci F, Ribizzi G, Cutrupi V, Cairoli R, Rapisarda V, Pastorello EA, Barocci S.
    Int J Immunogenet; 2011 Aug; 38(4):303-9. PubMed ID: 21545408
    [Abstract] [Full Text] [Related]

  • 5. Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis.
    Chung WH, Hung SI.
    J Dermatol Sci; 2012 Jun; 66(3):190-6. PubMed ID: 22541332
    [Abstract] [Full Text] [Related]

  • 6. HLA-B*1502 strongly predicts carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Thai patients with neuropathic pain.
    Kulkantrakorn K, Tassaneeyakul W, Tiamkao S, Jantararoungtong T, Prabmechai N, Vannaprasaht S, Chumworathayi P, Chen P, Sritipsukho P.
    Pain Pract; 2012 Mar; 12(3):202-8. PubMed ID: 21676164
    [Abstract] [Full Text] [Related]

  • 7. Association of Fas Ligand gene polymorphism with Stevens-Johnson syndrome.
    Ueta M, Sotozono C, Inatomi T, Kojima K, Hamuro J, Kinoshita S.
    Br J Ophthalmol; 2008 Jul; 92(7):989-91. PubMed ID: 18577653
    [Abstract] [Full Text] [Related]

  • 8. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D, Marzano A, Quaglino P, De Simone C, Parodi A, Barletta E, Fabbri P.
    Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421
    [Abstract] [Full Text] [Related]

  • 9. Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis.
    Chung WH, Hung SI.
    Allergol Int; 2010 Dec; 59(4):325-32. PubMed ID: 20962567
    [Abstract] [Full Text] [Related]

  • 10. Shared and restricted T-cell receptor use is crucial for carbamazepine-induced Stevens-Johnson syndrome.
    Ko TM, Chung WH, Wei CY, Shih HY, Chen JK, Lin CH, Chen YT, Hung SI.
    J Allergy Clin Immunol; 2011 Dec; 128(6):1266-1276.e11. PubMed ID: 21924464
    [Abstract] [Full Text] [Related]

  • 11. Specific association of the rs6500265 and rs9933632 single-nucleotide polymorphisms in Japanese patients with antipyretic analgesic-related Stevens-Johnson syndrome and toxic epidermal necrolysis with severe ocular involvements.
    Okamoto-Uchida Y, Nakamura R, Matsunaga K, Aihara M, Saito Y.
    Pharmacogenet Genomics; 2018 Mar; 28(3):95-98. PubMed ID: 29239905
    [Abstract] [Full Text] [Related]

  • 12. Investigation of TNF-alpha, TGF-beta 1, IL-10, IL-6, IFN-gamma, MBL, GPIA, and IL1A gene polymorphisms in patients with idiopathic thrombocytopenic purpura.
    Pehlivan M, Okan V, Sever T, Balci SO, Yilmaz M, Babacan T, Pehlıvan S.
    Platelets; 2011 Mar; 22(8):588-95. PubMed ID: 21591983
    [Abstract] [Full Text] [Related]

  • 13. Genome-wide association study of serious blistering skin rash caused by drugs.
    Shen Y, Nicoletti P, Floratos A, Pirmohamed M, Molokhia M, Geppetti P, Benemei S, Giomi B, Schena D, Vultaggio A, Stern R, Daly MJ, John S, Nelson MR, Pe'er I, International Serious Adverse Events Consortium (SAEC).
    Pharmacogenomics J; 2012 Apr; 12(2):96-104. PubMed ID: 21221126
    [Abstract] [Full Text] [Related]

  • 14. [Stevens-Johnson syndrome and toxic epidermal necrolysis--updates and innovations].
    Halevy S.
    Harefuah; 2010 Mar; 149(3):186-90, 193. PubMed ID: 20684173
    [Abstract] [Full Text] [Related]

  • 15. Toll-like receptor 3 gene polymorphisms in Japanese patients with Stevens-Johnson syndrome.
    Ueta M, Sotozono C, Inatomi T, Kojima K, Tashiro K, Hamuro J, Kinoshita S.
    Br J Ophthalmol; 2007 Jul; 91(7):962-5. PubMed ID: 17314152
    [Abstract] [Full Text] [Related]

  • 16. Ocular surface inflammation mediated by innate immunity.
    Ueta M, Kinoshita S.
    Eye Contact Lens; 2010 Sep; 36(5):269-81. PubMed ID: 20703156
    [Abstract] [Full Text] [Related]

  • 17. Pharmacogenetics of toxic epidermal necrolysis.
    Lee MT, Hung SI, Wei CY, Chen YT.
    Expert Opin Pharmacother; 2010 Sep; 11(13):2153-62. PubMed ID: 20536296
    [Abstract] [Full Text] [Related]

  • 18. Toll-like receptor 9 polymorphism in patients with erythema multiforme, Stevens Johnson syndrome and Stevens Johnson syndrome/toxic epidermal necrolysis overlap syndrome.
    Turan H, Bulbul Baskan E, Yakut T, Karkucak M, Tunali S, Saricaoglu H.
    Bratisl Lek Listy; 2011 Sep; 112(5):260-3. PubMed ID: 21682079
    [Abstract] [Full Text] [Related]

  • 19. Stevens-Johnson syndrome and toxic epidermal necrolysis due to anticonvulsants share certain clinical and laboratory features with drug-induced hypersensitivity syndrome, despite differences in cutaneous presentations.
    Teraki Y, Shibuya M, Izaki S.
    Clin Exp Dermatol; 2010 Oct; 35(7):723-8. PubMed ID: 19874350
    [Abstract] [Full Text] [Related]

  • 20. Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment.
    Murata J, Abe R, Shimizu H.
    J Allergy Clin Immunol; 2008 Nov; 122(5):992-1000. PubMed ID: 18692887
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 16.